Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$23.18 +0.14 (+0.61%)
As of: Sep 10, 2026 · 10:17 AM EDT

Amphastar Pharmaceuticals (AMPH) EPS (Diluted) (2013 - 2026)

Analysis

Amphastar Pharmaceuticals (AMPH) EPS (Diluted) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Teva Pharmaceutical Industries 42.62 Bn 38.96 Bn 2.15 Bn -0.49
2 Viatris 18.96 Bn 18.08 Bn 1.46 Bn -0.10
3 Dr Reddys Laboratories 9.79 Bn 9.61 Bn 396.53 Mn 0.06
4 Amneal Pharmaceuticals 5.49 Bn 5.36 Bn 334.51 Mn 0.21
5 Bausch Health Companies 2.29 Bn 453.25 Mn 2.10 Bn 0.69
6 Alvotech 1.51 Bn 1.36 Bn 2.56 Mn -0.23
7 Ani Pharmaceuticals 1.50 Bn 1.14 Bn 165.89 Mn 1.13
8 Amphastar Pharmaceuticals 1.01 Bn 719.36 Mn 93.47 Mn 0.69
9 Fennec Pharmaceuticals 401.07 Mn 359.82 Mn 17.15 Mn 0.05
10 RedHill Biopharma 173.61 Mn 173.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.69
Mar 31, 2026 0.14
Dec 31, 2025 0.61
Sep 30, 2025 0.36
Jun 30, 2025 0.64
Mar 31, 2025 0.51
Dec 31, 2024 0.50
Sep 30, 2024 0.78
Jun 30, 2024 0.73
Mar 31, 2024 0.83
Dec 31, 2023 0.63
Sep 30, 2023 0.92
Jun 30, 2023 0.50
Mar 31, 2023 0.52
Dec 31, 2022 0.56
Sep 30, 2022 0.30
Jun 30, 2022 0.33
Mar 31, 2022 0.48
Dec 31, 2021 0.40
Sep 30, 2021 0.62